FI951778A0 - Menetelmä allergian toteamiseksi - Google Patents

Menetelmä allergian toteamiseksi

Info

Publication number
FI951778A0
FI951778A0 FI951778A FI951778A FI951778A0 FI 951778 A0 FI951778 A0 FI 951778A0 FI 951778 A FI951778 A FI 951778A FI 951778 A FI951778 A FI 951778A FI 951778 A0 FI951778 A0 FI 951778A0
Authority
FI
Finland
Prior art keywords
allergy
pct
probability
date
sec
Prior art date
Application number
FI951778A
Other languages
English (en)
Swedish (sv)
Other versions
FI951778A (fi
Inventor
Esa-Matti Lilius
Erika Isolauri
Seppo Salminen
Original Assignee
Aboatech Ab Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aboatech Ab Oy filed Critical Aboatech Ab Oy
Priority to FI951778A priority Critical patent/FI951778A/fi
Publication of FI951778A0 publication Critical patent/FI951778A0/fi
Priority to EP96910050A priority patent/EP0820594B1/en
Priority to DE69618451T priority patent/DE69618451T2/de
Priority to AU53367/96A priority patent/AU708909B2/en
Priority to PCT/FI1996/000199 priority patent/WO1996032645A1/en
Priority to US08/647,965 priority patent/US5858690A/en
Priority to AT96910050T priority patent/ATE211825T1/de
Priority to CA002217898A priority patent/CA2217898A1/en
Publication of FI951778A publication Critical patent/FI951778A/fi

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/805—Drug, bio-affecting and body treating compositions involving IgE or IgD
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/809—Drug, bio-affecting and body treating compositions involving immunoglobulin or antibody fragment, e.g. fab', fv, fc, heavy chain or light chain
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/81—Drug, bio-affecting and body treating compositions involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, immunotolerance, or anergy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Encapsulation Of And Coatings For Semiconductor Or Solid State Devices (AREA)
  • Sorption Type Refrigeration Machines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
FI951778A 1995-04-12 1995-04-12 Menetelmä allergian toteamiseksi FI951778A (fi)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FI951778A FI951778A (fi) 1995-04-12 1995-04-12 Menetelmä allergian toteamiseksi
EP96910050A EP0820594B1 (en) 1995-04-12 1996-04-12 Method for detecting allergy
DE69618451T DE69618451T2 (de) 1995-04-12 1996-04-12 Verfahren zur feststellung einer allergie
AU53367/96A AU708909B2 (en) 1995-04-12 1996-04-12 Method for detecting allergy
PCT/FI1996/000199 WO1996032645A1 (en) 1995-04-12 1996-04-12 Method for detecting allergy
US08/647,965 US5858690A (en) 1995-04-12 1996-04-12 Method for detecting allergy
AT96910050T ATE211825T1 (de) 1995-04-12 1996-04-12 Verfahren zur feststellung einer allergie
CA002217898A CA2217898A1 (en) 1995-04-12 1996-04-12 Method for detecting allergy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI951778A FI951778A (fi) 1995-04-12 1995-04-12 Menetelmä allergian toteamiseksi

Publications (2)

Publication Number Publication Date
FI951778A0 true FI951778A0 (fi) 1995-04-12
FI951778A FI951778A (fi) 1996-10-13

Family

ID=8543239

Family Applications (1)

Application Number Title Priority Date Filing Date
FI951778A FI951778A (fi) 1995-04-12 1995-04-12 Menetelmä allergian toteamiseksi

Country Status (8)

Country Link
US (1) US5858690A (fi)
EP (1) EP0820594B1 (fi)
AT (1) ATE211825T1 (fi)
AU (1) AU708909B2 (fi)
CA (1) CA2217898A1 (fi)
DE (1) DE69618451T2 (fi)
FI (1) FI951778A (fi)
WO (1) WO1996032645A1 (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001078704A2 (en) * 2000-04-13 2001-10-25 Evans William T Gaba substrate and the use thereof for treating cognitive and emotional disorders
US20030022250A1 (en) * 2001-05-29 2003-01-30 Dreskin Stephen C. Functional IgE test methods and compositions
FI115165B (fi) 2001-06-04 2005-03-15 Aboatech Ab Oy Menetelmä infektion laadun määrittämiseksi
CN104677810B (zh) * 2015-01-30 2017-08-22 广东医学院附属医院 嗜碱性粒细胞活化的检测试剂盒及其使用方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4693967A (en) * 1981-02-18 1987-09-15 Research Corporation Monitoring therapy results in body samples of receptor cells
US5192665A (en) * 1985-11-22 1993-03-09 Labsystems, Oy Method of ophthalmic testing
US4954617A (en) * 1986-07-07 1990-09-04 Trustees Of Dartmouth College Monoclonal antibodies to FC receptors for immunoglobulin G on human mononuclear phagocytes
US5409901A (en) * 1987-07-02 1995-04-25 Calabrese; Alberto I. Therapeutic compositions comprising nucleoproteins as the active agents, and methods of producing and using such compositions
US5219997A (en) * 1987-07-06 1993-06-15 Dana-Farber Cancer Institute Monoclonal antibody which inhibits the adhesion functions of the β integrin, CR3
ES2035317T5 (es) * 1987-11-09 1998-03-16 Becton Dickinson Co Metodo para analizar celulas hematopoyeticas en una muestra.
US5256642A (en) * 1988-04-01 1993-10-26 The Johns Hopkins University Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof
US5547669A (en) * 1989-11-03 1996-08-20 Immulogic Pharma Corp Recombinant peptides comprising T cell epitopes of the cat allergen, Fel d I
US5567594A (en) * 1991-04-26 1996-10-22 Enteron, L.P. Methods and compositions for the detection and treatment of diseases associated with antigens of microorganisms
EP0559871B1 (en) * 1991-10-01 1997-01-22 Alain Ladislas De Weck Method for an in vitro diagnosis of allergies and other inflammatory diseases

Also Published As

Publication number Publication date
EP0820594B1 (en) 2002-01-09
DE69618451D1 (de) 2002-02-14
AU708909B2 (en) 1999-08-12
EP0820594A1 (en) 1998-01-28
CA2217898A1 (en) 1996-10-17
AU5336796A (en) 1996-10-30
FI951778A (fi) 1996-10-13
DE69618451T2 (de) 2002-09-26
ATE211825T1 (de) 2002-01-15
US5858690A (en) 1999-01-12
WO1996032645A1 (en) 1996-10-17

Similar Documents

Publication Publication Date Title
HUP0301020A2 (hu) Konformációs betegségek korai diagnosztikája
EP1099102A4 (en) TRACE DETECTION OF ANALYTES BY ARTIFICIAL OLFAKTOMETRY
EP0792458A4 (en) METHOD FOR ASSISTING THE DIAGNOSIS OF ALZHEIMER'S DISEASE BY MEASURING AMYLOID-BETA PEPTIDE (X-41) AND TAU PROTEIN
DE69510336D1 (de) Verfahren zur diagnose von praeklampsie
ATE234466T1 (de) Verfahren zur feststellung von antipolymerantikörper und diagnosetestsatz zur feststellung von siliconabhängigen krankheiten
ATE422671T1 (de) Verfahren zur diagnose von morbus alzheimer
ATE293704T1 (de) Methode und zusammensetzungen für die diagnose von extra-esophagem reflux
DE69122761D1 (de) Verfahren und komposition zum frühnachweiss und behandlung insulinabhängiger diabetes
FI951778A0 (fi) Menetelmä allergian toteamiseksi
DK0568554T3 (da) Fremgangsmåde til påvisning af anti-RNA-antistoffer
PT815451E (pt) Processo de analise das poeiras domesticas
SE9401883L (sv) Sätt vid diagnosticering av födoämnesintolerans/allergi samt instrument för diagnostiseringen
DK0720745T3 (da) Fremgangsmåde til kvantificering af ekstracellulært BPI i legemsvæsker
DE50007635D1 (de) Verfahren zur diagnose von sjögren-syndrom
DE60038614D1 (de) Verfahren zur diagnose von synovialen oder osteoartikulären erkrankungen
DE69214843D1 (de) Verfahren zum nachweis von beschädigungen des magenepithels
FI973418A (fi) Vasta-ainetuotannon toteaminen
DE69431051D1 (de) Verfahren zur bestimmung der diabetesanfälligkeit bei asymptomatischen patienten
EP0563244A4 (en) Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis
ATE459877T1 (de) Diagnostikum für die frühe phase von morbus alzheimer
ATE237139T1 (de) Verfahren zur identifizierung personen empfindlich für betahemolytischer streptococci- vermittelter neuropsychiatrischer krankheiten
DE69521145D1 (de) Verfahren zur kompetitiven bestimmung eines haptens
ATE220458T1 (de) Pyridinolin-quervernetzung als hinweis auf krankhafte vorgänge an periodontalen und peripheren implantaten
DE69912453D1 (de) Verfahren und materialien zur diagnose instabiler angina
FI943921A (fi) Vapaan trypsinogeeni-2:n määritys

Legal Events

Date Code Title Description
FD Application lapsed